Gastric cancer: Value of multimodality treatment;Aktueller stand multimodaler therapiekonzepte beim magenkarzinom

Viszeralchirurgie

Volumn 36, Issue 1, 2001, Pages 12-19

  Meyer, H J ^a   Wilke, H ^b  

^a Pathologisches Institut   (Germany)

^b KLINIKEN ESSEN MITTE   (Germany)

Author keywords

Evaluation of prognostic parameters; Gastric cancer; Multimodality treatment; R0 resection

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; INTERFERON; METHOTREXATE; MITOMYCIN C; TEGAFUR;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; GASTRECTOMY; HUMAN; HYPERTHERMIC THERAPY; MULTIMODALITY CANCER THERAPY; PEROPERATIVE CARE; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE TREATMENT; PROGNOSIS; STOMACH CANCER;

EID: 0035098640     PISSN: 14353067     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-11143     Document Type: Article

References (45)

1. Perspectives of surgery and multimodality treatment in gastric carcinoma
2. Stand der chirurgischen Studien in der Onkologie, Teil 1
3. Präoperatives Down-staging beim fortgeschrittenen Magenkarzinom
4. Prognostic factors in gastric carcinoma
5. Magenkarzinom. Optimierung durch neoadjuvante und adjuvante therapie?
6. Neue Therapieansätze bei tumoren des oberen Gastrointestinaltraktes (Ösophagus, Magen)
7. Anwendungspraxis multimodaler Therapiekonzepte beim Magenkarzinom in Deutschland
8. Magenkarzinom: Stellenwert der Lymphknotendissektion
9. Hypothetisches und Gesichertes zur prae-, intra- und postoperativen Zusatztherapie des Magenkarzinoms
10. Prinzipien der neoadjuvanten Therapie: Strategien zur präoperativen Therapie locoregionaler Krebserkrankungen: Eine Gelegenheit zur Erweiterung bestehender Konzepte
11. Biologische Grundlagen multimodaler Therapieansätze
12. Neoadjuvant therapy
13. Aktueller stand der neoadjuvanten Chemotherapie beim Magenkarzinom
14. How to prevent recurrences in gastric cancer-clinical improvement by multimodal treatment?
15. Preoperative therapy of local-regional gastric cancer: Rationale and review of trials
16. Gastric cancer therapy: A translational research paradigm
17. Neoadjuvant chemotherapy for high-grade advanced gastric cancer
18. A phase III randomised comparison of neoadjuvant chemotherapy followed by surgery versus surgery for locally advanced stomach cancer
19. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma
20. Preoperative chemotherapy for operable gastric cancer (POCOM): Results of the Dutch randomised trial
21. Preoperative chemotherapy of locally advanced gastric cancer
22. Neoadjuvant and postoperative chemotherapy for high risk patients with gastric cancer
23. Preoperative chemotherapy for stage III-IV gastric carcinoma
24. Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: A phase II study with etoposide, doxorubicin and cisplatin
25. Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5-fluorouracil
26. Epirubicin, etoposide and cisplatin in the treatment of locally advanced, nonresectable gastric carcinoma. Results of a multicentric pilot study
27. Advances in treatment of seriously advanced gastric cancer using aggressive EAP chemotherapy
28. Japan gastric trials in intraoperative radiation therapy
29. Die intraoperative radiotherapie als bestandteil multimodaler therapiekonzepte bei epithelialen tumoren des Gastrointestinaltrakts
30. Gesicherte und überlegenswerte Indikationen zur Strahlentherapie beim Magenkarzinom
31. Intraoperative radiation therapy for gastric carcinoma
32. Prophylaxis with carbon-addorbed mitomycin against peritoneal recurrence of gastric cancer
33. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer
34. Adjuvant intraperitoneal chemotherapy with carbon-adsorbed Mitomycin in patients with gastric cancer: Results of a randomized multicenter trial of the Austrian working group for surgical oncology
35. Ergebnisse der intraperitonealen Aktivkohle - Mitomycintherapie des Magencarcinoms mit Serosainvasion
36. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer
37. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study
38. Adjuvant therapy after curative resection for gastric cancer: Metaanalysis of randomized trials
39. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up
40. Adjuvant chemotherapy in gastric cancer
41. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer
42. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients
43. Efficacy of adjuvant mitomycin C plus tegafur in stage III gastric cancer
44. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and G. E. junction. Results of Intergroup Study INR-0116
45. Inadequate documentation and resection for gastric cancer in the United States : A preliminary report